Genetic polymorphisms and cerebrovascular disease in children with sickle cell anemia from Rio de Janeiro, Brazil;Polimorfismos genéticos e doença cerebrovascular em crianças com anemia falciforme do Rio do Janeiro, Brasil

Arquivos de Neuro-Psiquiatria

Volumn 69, Issue 3, 2011, Pages 431-435

  Filho, Isaac Lima da Silva ^a   Leite, Ana Claudia Celestino Bezerra ^a,b   Moura, Patrícia Gomes ^b   Ribeiro, Georgina Severo ^c   Cavalcante, Andréa Cony ^b   Azevedo, Flávia Carolina Marques ^b   de Andrada Serpa, Maria José ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b Instituto Estadual de Hematologia Arthur de Siqueira Cavalcante   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Alpha thalassemia; Beta globin haplotypes; Cerebrovascular disease; Genetic polymorphism; Sickle cell anemia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETA GLOBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADOLESCENT; ALPHA THALASSEMIA; ARTICLE; BRAZIL; CEREBROVASCULAR DISEASE; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79960604526     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2011000400004     Document Type: Article

References (29)

1. Steinberg MH, Adewoye AH. Modifier genes and sickle cell anemia. Curr Opin Hematol 2006;13:131-136.
2. Adams GT, Snieder H, McKie VC, et al. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genome wide screen. BMC Medical Genetics 2003;4:6.
3. Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 2003;115:721-728.
4. Ohene-Frempong KO, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-294.
5. Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002;99:3014-3018.
6. Adams JR. Big strokes in small persons. Arch Neurol 2007;64:1567-1574.
7. Driscoll MC, Hurlet A, Styles L, et al. Stroke risk in siblings with sickle cell anemia. Blood 2003;101:2401-2404.
8. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005;129:465-481.
9. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
10. Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of beta-like globin cluster haplotypes. Am J Hematol 1989;32:66-69.
11. Chong SS, Boehm CD, Higgs DR. et al. Single-tube multiplex-PCR screen for common deletional determinants of a-thalassemia. Blood 2000;95:360-362.
12. Frosst T, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahyfolate reductase. Nat Genet 1995;10:111-113.
13. Zöller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343:1536-1538.
14. Poort SR, Rosendal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-unstraslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood 1996;88:3698-3703.
15. Sarnaik SA, Ballas SK. Molecular characteristics of pediatric patients with sickle cell anemia and stroke. Am J Hematol 2001;67:179-182.
16. Neonato MG, Guilloud-Bataille M, Beauvais P, et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol 2000;65:155-164.
17. Wenning MR, Kimura EM, Costa FF, et al. a-Globin genes: thalassemic and structural alterations in a Brazilian population. Braz J Med Biol Res 2000; 33:1041-1045.
18. Menzel S, Thein SL. Genetic architecture of hemoglobin F control. Curr Opin Hematol 2009;16:179-186.
19. Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. Pediatrics 1999;103:640-645.
20. Bernaudin F, Verlhac S, Chevret S. G6PD deficiency, absence of {alpha}- thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 2008;112:4314-4317.
21. Adorno EV, Zanette AL, Lyra I, et al. Clinical and molecular characteristics of sickle cell anemia in the northeast of Brazil. Genetics Mol Biol 2008;31: 621-625.
22. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002;288:2015-2021.
23. Goracy I, Cyrylowski L, Kaczmarczyk M, et al. C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects. J Appl Genet 2009;50:63-67.
24. Cumming AM, Olujohungbe A, Keeney S, Singh H, Hay CR, Serjeant GR. The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke. Br J Haematol 1999;107:569-571.
25. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of Factor V Leiden in 4047 Men and women: implications for venous thromboembolism screening. JAMA 1997; 277:1305-1307.
26. Segal JB, Brotman DJ, Necochea AJ, et al. Predictive value of Factor V leiden and prothrombin G20210A in adults with venous thromboembolism. JAMA 2009;301:2472-2485.
27. Andrade FL, Annichino-Bizzacchi AJM, Saad ST, Costa FF, Arruda VR. Prothrombin mutant, Factor V Leiden and thermolabile variant of methylenetetrahydrofolate reductase amog patients with sickle cell disease in Brazil. Am J Hematol 1998;59:46-50.
28. Neto FM, Lourenço DM, Noguiti MAE, et al. The clinical impact of MTHFR polymorphisms on the vascular complications of sickle cell disease. Braz Med Biol Res 2006;39:1291-1295.
29. Couto FD, Vilas Boas W, Lyra I, et al. A C677T methylenetetrahydrofolate reductase (MTHFR) polymorphisms and G20210A mutation in the prothrombin gene of sickle cell anemia patients from Northeast Brazil. Hemoglobin 2004;28:237-241.